comprehensive -WSS

comprehensive

author：hotspot 2025-10-01 18:32:18 - browse：78491

close-up of psoriasis on a hand. -- biotech coverage from STAT — A close-up of psoriasis on a hand. Adobe

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis.

Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

Alumis’ lead drug, ESK-001, is an oral medicine designed to help patients with the most common type of psoriasis by inhibiting a signaling protein called TYK2. Research has shown that the TYK2 protein plays a role in diseases where the immune system overreacts, which has made it a popular drug target in recent years.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Midwives could help bridge maternal health disparities in the U.S.

hotspot

WSS

Senators: Long

Lasker Awards 2023: Winners in biomedical research

The unintended consequences of overturning Roe v. Wade

Thermo Fisher plant for manufacturing gene therapies to expand

Covid’s new normal has set in amid another rise in cases

Medicare to pay more for cardiac rehab in hospital outpatient clinics

focus

comprehensive

knowledge

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Patients, doctors press FTC to beef up hospital merger scrutiny

Virginia high school admissions case could be legal follow

Chamber of Commerce, DOJ clash in court over drug prices

Affirmative action in medical school literally saved lives

Biotech lab space demand falls sharply

At least 13 dead in Texas as scorching temps continue

Emergency workers more likely to restrain Black patients: study

Apple is now the first public company to be valued at $3 trillion

Experts study whether long Covid risk adds up with each reinfection

hotspot

Readout LOUD podcast: possible new ALS drug, artificial wombs

What happened to the House vote on health price transparency?

FDA panel to weigh safety of artificial wombs for preterm births

Information blocking fines are now fair game in health care

What happened to the House vote on health price transparency?

David Liu startup to focus on CRISPR delivery

focus

hotspot

hotspot

knowledge